Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610035 | PMC |
| http://dx.doi.org/10.5114/ada.2020.94743 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rosacea Fulminans following Initiation of Deucravacitinib.
Clin Exp Dermatol
November 2024
Sinclair DIRECT, Dermatology Investigational Research, Education and Clinical Trials Centre, Melbourne, VIC, Australia.
Rosacea Fulminans in Pregnancy: A Case Report and Review.
Clin Cosmet Investig Dermatol
September 2024
Department of Dermatology, Hangzhou Third People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
Rosacea is a common dermatosis with multiple pathogeneses, among which, rosacea fulminans may serve as a rare but severe subtype. This inflammatory disease usually presents as abrupt multiple erythema, pustules, and nodules localized on the face. Pregnancy and related changes of hormone levels may play a key role in the development and progression of the disease, although the exact mechanisms are unknown.
View Article and Find Full Text PDFA case of rosacea fulminans during pregnancy.
J Dtsch Dermatol Ges
November 2023
Dermatology Department, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy.
Isotretinoin-associated acne fulminans: A multicentre, retrospective study of the European Academy of Dermatology and Venereology Task Force on Acne, Rosacea and Hidradenitis Suppurativa.
J Eur Acad Dermatol Venereol
January 2024
Departments of Dermatology, Venereology, Allergology and Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.
Background: Acne fulminans (AF) is a rare severe acne entity. Although occasionally reported, it is unclear whether AF development is associated with oral isotretinoin treatment.
Objectives: To investigate the occurrence of isotretinoin-associated AF, clinical characteristics and prognosis at follow-up.
Severe papulopustular rosacea successfully treated with a combination of oral azithromycin and isotretinoin.
J Dermatolog Treat
December 2022
Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.
Papulopustular rosacea is notoriously a challenge to treat, and treatment options are scarce. Only limited data exist on the use of azithromycin in treatment of papulopustular rosacea. However, the unique pharmacokinetics of azithromycin may have several indications in the treatment of papulopustular rosacea.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!